LONDON--(BUSINESS WIRE)--Keyron, developer of the ForePass® fully reversible metabolic bypass platform for severe metabolic disease, today announced that David Feigal, MD, was appointed Board Chair effective September 21, 2026. Dr Feigal will continue to lead Keyron’s regulatory strategy alongside his new role as Board Chair. He is the former Director of the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH), which regulates medical devices in the United State
Keyron Appoints Former FDA Medical Device Center Director David Feigal as Board Chair
